ðŸ‡ðŸ‡° English, 12 November 2026, drug discovery
Geodesic Intelligence's NovaAtom-Lite Tops State-of-the-Art in Drug Discovery Tasks
A life sciences AI model from Geodesic Intelligence outperforms state-of-the-art systems in several drug discovery tasks.
A former ByteDance AI scientist’s new venture has released a life sciences AI model that the firm claims outperforms state-of-the-art systems, intensifying the increasingly crowded competition in AI-driven drug discovery. Geodesic Intelligence’s NovaAtom-Lite, an AI model designed to predict the structures and interactions of biomolecules, topped a third-party benchmark in several drug discovery tasks, founder Quanquan Gu said on social media on Wednesday.